ArticleMolecular genetics and genomics : MGG2004
A novel small-molecule inhibitor of the chromosome segregation process in yeast.
Article in Molecular genetics and genomics : MGG, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
The centromeres of budding yeasts contain specific and essential DNA sequences, in contrast to the regional heterochromatic centromeres found in higher organisms. Small molecules that perturb centromere function in budding yeast could be valuable candidates for identifying yeast-specific growth inhibitors. A combination of two in vivo assays, one based on transcription blockade of a reporter gene by the centromeric DNA-protein complex, the other on a test for mitotic minichromosome stability, was used to identify small molecules that affect the process of chromosome segregation. One compound, here named incentrom A, leads to a minichromosome loss phenotype, and is cytotoxic to the budding yeast Saccharomyces cerevisiae. Furthermore, whereas cells carrying a conditional mutation in a gene for an essential kinetochore protein, skp1-4, are hypersensitive to incentrom A, cells that overexpress the SKP1 gene are resistant to the compound. Incentrom A also results in mitotic loss of a centromere-bearing plasmid, and inhibits the growth of the pathogenic yeast Candida glabrata. Incentrom A will therefore be a useful tool for studying the molecular basis of yeast chromosome segregation and could form the basis for the development of novel antifungal drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.